These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 22709654)

  • 1. Immunosuppression in the tumor microenvironment: where are we standing?
    Umansky V
    Semin Cancer Biol; 2012 Aug; 22(4):273-4. PubMed ID: 22709654
    [No Abstract]   [Full Text] [Related]  

  • 2. New insights into chronic inflammation-induced immunosuppression.
    Kanterman J; Sade-Feldman M; Baniyash M
    Semin Cancer Biol; 2012 Aug; 22(4):307-18. PubMed ID: 22387003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment.
    De Jaeghere EA; Denys HG; De Wever O
    Trends Cancer; 2019 Nov; 5(11):704-723. PubMed ID: 31735289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma-induced immunosuppression and its neutralization.
    Umansky V; Sevko A
    Semin Cancer Biol; 2012 Aug; 22(4):319-26. PubMed ID: 22349515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming tumor-mediated immunosuppression.
    Schlößer HA; Theurich S; Shimabukuro-Vornhagen A; Holtick U; Stippel DL; von Bergwelt-Baildon M
    Immunotherapy; 2014; 6(9):973-88. PubMed ID: 25341119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cell role in tumor-related inflammation.
    Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
    Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation in the Tumor Microenvironment.
    Lin Q; Jin S; Han M; Zheng W; Liu J; Wei X
    J Immunol Res; 2018; 2018():1965847. PubMed ID: 30035130
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance and immune suppression in the tumor microenvironment.
    Ostrand-Rosenberg S
    Cell Immunol; 2016 Jan; 299():23-9. PubMed ID: 26435343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the tumor microenvironment by immunotherapy: part 2.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1385-408. PubMed ID: 22053888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy.
    Zhang Y; Chen L
    JAMA Oncol; 2016 Nov; 2(11):1403-1404. PubMed ID: 27490017
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms.
    Lafont V; Lucas S; Bonnefoy N
    Front Immunol; 2021; 12():691899. PubMed ID: 34012459
    [No Abstract]   [Full Text] [Related]  

  • 12. The tumor microenvironment: part 1.
    Leibovici J; Itzhaki O; Huszar M; Sinai J
    Immunotherapy; 2011 Nov; 3(11):1367-84. PubMed ID: 22053887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The T-cell-inflamed tumor microenvironment as a paradigm for immunotherapy drug development.
    Olson DJ; Luke JJ
    Immunotherapy; 2019 Feb; 11(3):155-159. PubMed ID: 30730272
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing cancer vaccine efficacy via modulation of the tumor microenvironment.
    Disis ML
    Clin Cancer Res; 2009 Nov; 15(21):6476-8. PubMed ID: 19861446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer immunotherapy. Importance of overcoming immune suppression].
    Malvicini M; Puchulo G; Matar P; Mazzolini G
    Medicina (B Aires); 2010; 70(6):565-70. PubMed ID: 21163748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune oncology in focus].
    Wölfel T; Becker JC; Schmitt M
    Onkologie; 2013; 36 Suppl 4():7-11. PubMed ID: 23797364
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment.
    Huang Y; Wang HC; Zhao J; Wu MH; Shih TC
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dormancy of tumor cells].
    Strien L; Joensuu K; Heikkilä P
    Duodecim; 2013; 129(21):2245-52. PubMed ID: 24340675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Pagès F; Bay JO; Tartour E
    Bull Cancer; 2016 Nov; 103 Suppl 1():S119-S121. PubMed ID: 28057173
    [No Abstract]   [Full Text] [Related]  

  • 20. How Tumor Cell Dedifferentiation Drives Immune Evasion and Resistance to Immunotherapy.
    Li J; Stanger BZ
    Cancer Res; 2020 Oct; 80(19):4037-4041. PubMed ID: 32554552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.